HK1044336A1 - 治疗糖尿病及衰老相关性血管性并发症的吡啶衍生物 - Google Patents
治疗糖尿病及衰老相关性血管性并发症的吡啶衍生物 Download PDFInfo
- Publication number
- HK1044336A1 HK1044336A1 HK02105890.8A HK02105890A HK1044336A1 HK 1044336 A1 HK1044336 A1 HK 1044336A1 HK 02105890 A HK02105890 A HK 02105890A HK 1044336 A1 HK1044336 A1 HK 1044336A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compounds
- aging
- treatment
- discloses
- diabetic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN827CAL99 | 1999-10-06 | ||
| IN827CA1999 | 1999-10-06 | ||
| PCT/IB1999/001687 WO2001025209A1 (en) | 1999-10-06 | 1999-10-15 | Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1044336A1 true HK1044336A1 (zh) | 2002-10-18 |
Family
ID=11084921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK02105890.8A HK1044336A1 (zh) | 1999-10-06 | 1999-10-15 | 治疗糖尿病及衰老相关性血管性并发症的吡啶衍生物 |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1220843A1 (cs) |
| JP (1) | JP2003511370A (cs) |
| CN (1) | CN1329597A (cs) |
| AU (1) | AU5994499A (cs) |
| BR (1) | BR9915962A (cs) |
| CA (1) | CA2351075A1 (cs) |
| CZ (1) | CZ20011808A3 (cs) |
| HK (1) | HK1044336A1 (cs) |
| HU (1) | HUP0301687A2 (cs) |
| MX (1) | MXPA02003496A (cs) |
| PL (1) | PL348049A1 (cs) |
| WO (1) | WO2001025209A1 (cs) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1355645A4 (en) * | 2000-12-29 | 2005-02-23 | Alteon Inc | METHOD FOR THE TREATMENT OF FIBROUS OR OTHER IIIC INDICATIONS |
| DK1243581T3 (da) * | 2001-03-21 | 2005-10-31 | Torrent Pharmaceuticals Ltd | Pyridiniumforbindelser til behandling af AGE-relaterede sygdomme |
| CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
| PL365441A1 (en) | 2001-04-05 | 2005-01-10 | Torrent Pharmaceuticals Ltd. | Heterocyclic compounds for aging-related and diabetic vascular complications |
| JP2003137783A (ja) * | 2001-10-19 | 2003-05-14 | Torrent Pharmaceuticals Ltd | 美容及び治療用途におけるピリジニウム誘導体の使用のための組成物及び方法 |
| GB0328314D0 (en) * | 2003-12-05 | 2004-01-07 | Univ Bath | Therapeutics |
| WO2007132179A2 (en) * | 2006-05-15 | 2007-11-22 | University Of Bath | Therapeutics comprising pyridinium derivatives |
| JP2009155315A (ja) * | 2007-12-26 | 2009-07-16 | Fujiyakuhin Co Ltd | 注射剤 |
| CN102459175A (zh) * | 2009-05-07 | 2012-05-16 | 托蓝特医药公司 | 用于治疗糖尿病的哌啶衍生物 |
| ES2899694T3 (es) * | 2012-10-05 | 2022-03-14 | Sphaera Pharma Pte Ltd | Compuestos novedosos, su síntesis y sus usos |
| EP3280711A1 (en) * | 2015-04-08 | 2018-02-14 | Torrent Pharmaceuticals Limited | Novel pyridinium compounds |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH335521A (de) * | 1955-06-02 | 1959-01-15 | Cilag Ag | Verfahren zur Herstellung neuer quaternärer Salze |
| US3318787A (en) * | 1964-02-07 | 1967-05-09 | Udylite Corp | Electrodeposition of zinc |
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| JPS5936247B2 (ja) * | 1977-04-20 | 1984-09-03 | ティーディーケイ株式会社 | 電気的表示装置 |
| JPS55138742A (en) * | 1979-04-17 | 1980-10-29 | Fuji Photo Film Co Ltd | Silver halide emulsion developing method |
| JPH0253759A (ja) * | 1988-08-18 | 1990-02-22 | Hamari Yakuhin Kogyo Kk | 新規な４級アンモニウム化合物 |
| DD275872A1 (de) * | 1988-09-27 | 1990-02-07 | Univ Dresden Tech | Verfahren zur herstellung von 5h-pyrido[1',2':1,2]imidazo[5,4-c]chinolin-6-onen |
| BR9607598B1 (pt) * | 1995-01-18 | 2009-05-05 | composição farmacêutica, composição tópica, composição ocular e composto. | |
| WO1998044925A1 (en) * | 1997-04-04 | 1998-10-15 | Smithkline Beecham Corporation | Calcilytic compounds |
-
1999
- 1999-10-15 CZ CZ20011808A patent/CZ20011808A3/cs unknown
- 1999-10-15 WO PCT/IB1999/001687 patent/WO2001025209A1/en not_active Ceased
- 1999-10-15 EP EP99974071A patent/EP1220843A1/en not_active Withdrawn
- 1999-10-15 PL PL99348049A patent/PL348049A1/xx not_active Application Discontinuation
- 1999-10-15 CN CN99814055A patent/CN1329597A/zh active Pending
- 1999-10-15 JP JP2001528155A patent/JP2003511370A/ja active Pending
- 1999-10-15 AU AU59944/99A patent/AU5994499A/en not_active Abandoned
- 1999-10-15 CA CA002351075A patent/CA2351075A1/en not_active Abandoned
- 1999-10-15 HK HK02105890.8A patent/HK1044336A1/zh unknown
- 1999-10-15 HU HU0301687A patent/HUP0301687A2/hu unknown
- 1999-10-15 BR BR9915962-7A patent/BR9915962A/pt not_active IP Right Cessation
- 1999-10-15 MX MXPA02003496A patent/MXPA02003496A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2351075A1 (en) | 2001-04-12 |
| AU5994499A (en) | 2001-05-10 |
| PL348049A1 (en) | 2002-05-06 |
| CN1329597A (zh) | 2002-01-02 |
| EP1220843A1 (en) | 2002-07-10 |
| JP2003511370A (ja) | 2003-03-25 |
| CZ20011808A3 (cs) | 2001-08-15 |
| HUP0301687A2 (hu) | 2003-08-28 |
| BR9915962A (pt) | 2003-01-07 |
| WO2001025209A1 (en) | 2001-04-12 |
| MXPA02003496A (es) | 2005-06-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2344144A1 (en) | Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof | |
| RU2227800C2 (ru) | Новые эффекторы дипептидилпептидазы iv | |
| HK1045655A1 (zh) | 由二甲雙胍及伏降糖組合構成的藥劑成份 | |
| WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
| EP1283054A4 (en) | MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF | |
| EP1089738A4 (en) | ANTIMICROBIAL LOCKS COMPRISING DERIVATIVES OF TAURINAMIDE AND CARBOXYLIC ACIDS AND / OR THEIR SALTS | |
| CA2386690A1 (en) | Pharmaceutical tramadol salts | |
| WO2001036510A3 (en) | Use of poly(diallylamine) polymers | |
| CA2373852A1 (en) | Oligosaccharide aldonic acids and their topical use | |
| CA2476800A1 (en) | Crystals of glucopyranosyloxybenzyl benzene derivative | |
| HK1044336A1 (zh) | 治疗糖尿病及衰老相关性血管性并发症的吡啶衍生物 | |
| RU2001131722A (ru) | 5-[4-(6-Метокси-1-метил-1Н-бензимидазол-2-илметокси)бензил]-тиазолидин-2,4 -ди он гидрохлорид, обладающий гипогликемической активностью | |
| HK1042303A1 (zh) | 新的化合物 | |
| WO1996015784A3 (de) | 2,2-dichloralkancarbonsäuren, verfahren zu ihrer herstellung diese enthaltende arzneimittel, und ihre verwendung zur behandlung der insulinresistenz | |
| RU2005106234A (ru) | Применение ацетата анекортава для защиты остроты зрения пациентов с возрастной дегенерацией желтого пятна | |
| EP1634876A3 (en) | Heterocyclic compounds for the treatment of hyperlipidemia agents | |
| RU2001118854A (ru) | Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний | |
| CA2341949A1 (en) | Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses | |
| WO2000066550A8 (en) | New compounds | |
| JP2001039976A5 (cs) | ||
| EP1132083A3 (en) | Use of zinc tranexamate in the treatment of diabetes | |
| EP1057487A4 (en) | ANTIMICROBIAL COMPOSITIONS WITH SYNERGISTIC EFFECT, MEDICAMENTS CONTAINING THEREOF AND DENTISTRY HEALING PROCEDURES, THEIR MANUFACTURING METHOD AND ASSOCIATED COMPOSITIONS | |
| AU674376B2 (en) | 4-guanidinobutyramide for improving blood circulation | |
| AU3926093A (en) | Verapamil HC1 formulation and other ophthalmic solutions with buffer system for ocular administration | |
| WO2003039578A8 (en) | Treatment of congestive heart failure |